Gotham Asset Management’s Aerie Pharmaceuticals AERI Stock Holding History

Gotham Asset Management’s Portfolio AERI Stock Details AERI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-11,106	Closed	-$168K	–	1346
2022 Q3	$168K	Buy	+11,106	New	+$129K	0.01%	1099

Gotham Asset Management's AERI Position: Q4 2022 in Review

Gotham Asset Management sold out of Aerie Pharmaceuticals (AERI) in Q4 2022, closing a stake of 11,106 shares — an estimated $168K sold.

Gotham Asset Management first reported a position in AERI in Q3 2022 and held it in 1 quarter. The position peaked at $168K in Q3 2022. 0 funds tracked by Wall St. Rank hold AERI as of Q4 2022.

Gotham Asset Management reported no remaining Aerie Pharmaceuticals position as of Q4 2022 after selling out during the quarter.
Gotham Asset Management sold 11,106 Aerie Pharmaceuticals shares in Q4 2022, an estimated $168K.
Gotham Asset Management first reported a position in Aerie Pharmaceuticals in Q3 2022 and held it in 1 quarter.
Gotham Asset Management's Aerie Pharmaceuticals position peaked at $168K in Q3 2022.
0 funds tracked by Wall St. Rank held Aerie Pharmaceuticals as of Q4 2022.

Based on Gotham Asset Management's 13F filing for Q4 2022, filed 14 Feb 2023.